ISSUE NO. 26 — CDISC Data Standards
The Clinical Data I
Five Reasons to Place Early-Phase Clinical Research in Canada
A well-planned clinical program designed to meet the regulatory requirements for the jurisdictions where you plan to request market authorization can be conduct
Insights Care: Chris Perkin — A Forward Thinker in the Research Space!
Five Lesser-Known Uses for PCR
PCR testing has been in the spotlight as the most reliable way of screening for COVID-19 in patients since the beginning of the pandemic. But what is PCR? And what are its other uses?
Up Close and Personal With Marie-Hélène Raigneau, MBA, President
Marie-Hélène has been a leader in the drug development industry for close to 20 years.
ISSUE NO. 25 — Flexibility in Phase I Study Timing
Endpoints News: Canadian CRO Altasciences Kicks Off Client Manufacturing Expansion in Philadelphia
ISSUE NO. 24 — Shortening Drug Development Timelines with Asian Ethnobridging Trials
Future Science: Diversity and Inclusion in the Bioanalytical Industry — An Interview with Anahita Keyhani
Test Your Knowledge of Liquid-Filled Capsules
Thanks to updated screening methods and bioavailability enhancements, poorly soluble molecules comprise 70% to 80% of the small molecule products entering the drug development pipeline today. Since poorly soluble drugs are difficult to formulate as tablets, formulation scientists are looking to two-piece, liquid-filled hard-shell capsules as a solution.